These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9354829)

  • 1. A survey of blood component use in a German university hospital.
    Zimmermann R; Büscher M; Linhardt C; Handtrack D; Zingsem J; Weisbach V; Eckstein R
    Transfusion; 1997 Oct; 37(10):1075-83. PubMed ID: 9354829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey of blood utilization in children and adolescents in a German university hospital.
    Zimmermann R; Handtrack D; Zingsem J; Weisbach V; Neidhardt B; Glaser A; Eckstein R
    Transfus Med; 1998 Sep; 8(3):185-94. PubMed ID: 9800290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood component use in a sub-Saharan African country: results of a 4-year evaluation of diagnoses associated with transfusion orders in Namibia.
    Pitman JP; Wilkinson R; Liu Y; von Finckenstein B; Smit Sibinga CT; Lowrance DW; Marfin AA; Postma MJ; Mataranyika M; Basavaraju SV
    Transfus Med Rev; 2015 Jan; 29(1):45-51. PubMed ID: 25573416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study of blood usage by diagnoses in a Korean university hospital.
    Lim YA; Lee WG; Cho SR; Hyun BH; Sc D
    Vox Sang; 2004 Jan; 86(1):54-61. PubMed ID: 14984561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audit on the usage of plasma derived/recombinant coagulation factor concentrates at a German university hospital.
    Strobel J; Jörns H; Weisbach V; Ganslandt T; Zimmermann R; Eckstein R
    Vox Sang; 2012 Aug; 103(2):122-9. PubMed ID: 22348748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the utilization of blood components in San Pablo Hospital; 1991-1996.
    Hunter Mellado R
    Bol Asoc Med P R; 1997; 89(1-3):4-8. PubMed ID: 9168628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of blood and its components in two gynecological-obstetrical wards of selected Silesian hospitals in years 1996-2002].
    Dylag S; Kucharz EJ
    Pol Merkur Lekarski; 2011 Mar; 30(177):195-201. PubMed ID: 21544997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transfusing methylene blue-photoinactivated plasma instead of FFP is associated with an increased demand for plasma and cryoprecipitate.
    Atance R; Pereira A; Ramírez B
    Transfusion; 2001 Dec; 41(12):1548-52. PubMed ID: 11778070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of inpatient use of fresh frozen plasma and other therapies and associated outcomes in patients with major bleeds from vitamin K antagonism.
    Magee G; Peters C; Zbrozek A
    Clin Ther; 2013 Sep; 35(9):1432-43. PubMed ID: 23954093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of red cell use in 45 hospitals in central Ontario, Canada.
    Chiavetta JA; Herst R; Freedman J; Axcell TJ; Wall AJ; van Rooy SC
    Transfusion; 1996 Aug; 36(8):699-706. PubMed ID: 8780664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four-year survival of transfusion recipients identified by hepatitis C lookback.
    Vamvakas EC; Goldstein R
    Transfusion; 2002 Jun; 42(6):691-7. PubMed ID: 12147020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of errors in blood component transfusion records with regard to quality improvement of data acquisition and to the performance of lookback and traceback procedures.
    Zimmermann R; Linhardt C; Weisbach V; Büscher M; Zingsem J; Eckstein R
    Transfusion; 1999 Apr; 39(4):351-6. PubMed ID: 10220259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of blood and blood component transfusion recipients in Zimbabwe.
    Mafirakureva N; Khoza S; Hassall O; Faragher BE; Kajja I; Mvere DA; Emmanuel JC; Postma MJ; van Hulst M
    Blood Transfus; 2015 Oct; 13(4):600-9. PubMed ID: 26192782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of transfusion recipients in Bordeaux University Hospital. A descriptive study using hospital claims and haemovigilance system databases].
    de Pommerol M; Gilleron V; Kostrzewa A; Roger I; Boiron JM; Salmi LR
    Transfus Clin Biol; 2010 Oct; 17(4):223-31. PubMed ID: 20965767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suitability of casemix classification for output funding of blood services in Victoria. Victorian Blood Users Group.
    Whyte GS; Brook CW
    Med J Aust; 1998 Oct; 169(8):415-8. PubMed ID: 9830388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.
    Asfour M; Narvios A; Lichtiger B
    MedGenMed; 2004 Jul; 6(3):22. PubMed ID: 15520646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collection and transfusion of blood and blood components in the United States, 1989.
    Wallace EL; Surgenor DM; Hao HS; An J; Chapman RH; Churchill WH
    Transfusion; 1993 Feb; 33(2):139-44. PubMed ID: 8430453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion practice in central Virginia.
    Cook SS; Epps J
    Transfusion; 1991 May; 31(4):355-60. PubMed ID: 1902337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring transfusion practices at two university hospitals.
    Titlestad K; Georgsen J; Jorgensen J; Kristensen T
    Vox Sang; 2001 Jan; 80(1):40-7. PubMed ID: 11339067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of blood products in Denmark in 1993. Regional differences and comparison with other Scandinavian and European countries].
    Kristensen T; Jerslid C; Kristensen K; Georgsen J
    Ugeskr Laeger; 1995 Jul; 157(27):3883-7. PubMed ID: 7645061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.